Answers are grounded in this paper and cite their sources.
Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients. The side effect profile of buspirone was less disruptive than that of imipramine. Buspirone was not significantly superior to placebo in its antipanic or anxiolytic effects in panic disorder patients.
No takes yet. Share an insight, caveat, or question.
Sheehan et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: